Perfil
Geoffrey A. Strange is currently the Chief Research & Strategy Officer at EchoIQ Ltd. and the Chief Medical Officer at LTR Pharma Ltd. Previously, he served as the Chief Executive Officer of The Pulmonary Hypertension Society of Australia & New Zealand from 2009 to 2021.
He also worked as the Global Medical Director at Anteris Technologies Ltd.
Cargos activos de Geoffrey A. Strange
| Empresas | Cargo | Inicio |
|---|---|---|
| VERILUMA | Director Técnico/Científico/I+D | - |
| LTR PHARMA LIMITED | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Geoffrey A. Strange.
| Empresas | Cargo | Fin |
|---|---|---|
The Pulmonary Hypertension Society of Australia & New Zealand | Director Ejecutivo | 01/06/2021 |
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Health Technology |
The Pulmonary Hypertension Society of Australia & New Zealand | |
EchoIQ Ltd.
EchoIQ Ltd. Other Metals/MineralsNon-Energy Minerals Develops and commercializes software products | Non-Energy Minerals |
Ltr Pharma Ltd.
Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Bolsa de valores
- Insiders
- Geoffrey A. Strange
















